Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids)
Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169)
10/2005
10/19/2005CN1684681A Bicifadine formulation
10/19/2005CN1684673A Electrospun amorphous pharmaceutical compositions
10/19/2005CN1683395A Nuclear factor-K B P65 subunit antagonistic peptide and its use
10/19/2005CN1683385A Ibuprofen sugar derivative and its preparing process and use
10/19/2005CN1683347A Substituted aryl methylene sulfonylated aza cyclo-pentanone compounds, its medicine compositions and its preparing process and use
10/19/2005CN1683017A Heating induction method for local expression of anti-inflammation gene
10/19/2005CN1682990A Medicinal preparation for treating rheumatism and rheumatoid diseases
10/19/2005CN1682964A Medicine for treating oviduct blocking caused by salpingitis and its preparing process
10/19/2005CN1682955A Refining method for caoshanhu by menbrane technology separation
10/19/2005CN1682927A Decumbent corydalis tuber freeze-dried powder injection and its preparing method
10/19/2005CN1682914A Capsule for treating arthralgia-syndrome
10/19/2005CN1682913A Anti-inflammation analgetic composition
10/19/2005CN1682897A Preparing anti-inflammatory component of bighead atractylodes rhizome volatile oil part and use in preparing anti-inflammatory medicines
10/19/2005CN1682889A Use of water melon young fruit in preparing medicine for treating fever and tetanus
10/19/2005CN1682886A External application Chinese medicine composition for treating rheumatism, rheumatoid diseases and chronic pain
10/19/2005CN1682883A Sarcandra solid dispersion and its preparing method
10/19/2005CN1682866A Pure Chinese medicine original medicinal pad for diminishing inflammation, relieving pain and dissipating mass
10/19/2005CN1682836A Qingkailing dispersing tablet
10/19/2005CN1682815A Gentongping dripping pill for treating wind-cold channel blocking and its preparing method
10/19/2005CN1682811A Strengthening spine and bone pill ofr treating rigid spondylitis
10/19/2005CN1682788A Shutongfang for killing pain and its preparation and use
10/19/2005CN1682786A Adhesive plaster
10/19/2005CN1682781A Eggplant root extract and its preparing method and use
10/19/2005CN1682770A Process for preparing bee glue water solution and use
10/19/2005CN1682755A Material for treating inflammation and pain
10/19/2005CN1682748A Chinese medicine preparation for treating rheumatism and preparation and use
10/19/2005CN1682742A Use of 23-hydroxy betulic acid in inhibiting blood vessel formation
10/19/2005CN1682733A Anti-cancer analgetic preparation
10/19/2005CN1682732A Medicinal composition having antiseptic and anti-inflammatory function
10/19/2005CN1682731A Medicine having anti-infection and analgetic function
10/19/2005CN1682711A Medicinal composition with function of clearing away heat and toxic material
10/19/2005CN1682708A External use analgesic cream for transfusion
10/19/2005CN1682705A Skin plaster containing aceclofenac
10/19/2005CN1682701A Self microemulsifying preparation of curcumin and its preparing process
10/19/2005CN1223591C Piperazine oxime derivatives having Nk-1 receptor antagonistic activity
10/19/2005CN1223578C Medical compound with antalgic, anti-inflammation and thrombocyte decoagulation function
10/19/2005CN1223347C Aqueous cilostazol preparation for injection
10/19/2005CN1223346C Pharmaceutical and nutritional compositions containing essential fatty acids and homocysteine-lowering agents
10/19/2005CN1223340C Electrospun pharmaceutical compositions
10/18/2005US6956059 use in relief of rheumatoid arthritis, rheumatoid spondylitis, osteroarthritis, gouty arthritis and other arthritic conditions, inflamed joints, eczema and other inflammatory skin conditions, inflammatory eye conditions, aids, hiv
10/18/2005US6956052 treatment of cancer and inflammation-associated disorders, such as arthritis; for example,1-[4-(aminosulfonyl)phenyl]-8-{[(trifluoromethyl)sulfonyl]amino}-4,5-dihydro-1H-benzo[g]indazole-3-carboxamide
10/18/2005US6956051 amphiphilic drug-oligomer conjugates comprising a therapeutic compound conjugated to an oligomer, wherein the oligomer comprises a lipophilic moiety coupled to a hydrophilic moiety; therapeutic agents coupled to amphiphilic oligomers
10/18/2005US6956050 Imidazole compounds as anti-inflammatory and analgesic agents
10/18/2005US6956046 4-hydroxypiperidine derivatives having analgesic activity
10/18/2005US6956045 Anticancer agents; antiallergens; immunology diseases; antiinflamamtory agents
10/18/2005US6956042 N-aryl diazaspiracyclic compounds and methods of preparation and use thereof
10/18/2005US6956041 Protein kinase inhibitors
10/18/2005US6956037 Benzamide derivatives for the treatment of diseases mediated by cytokines
10/18/2005US6956033 3,4-dihydroisoquinoline derivative compound and a pharmaceutical agent comprising it as active ingredient
10/18/2005US6955898 Targeting pharmaceutical agents to injured tissues
10/18/2005US6955815 Combinations for the treatment of inflammatory disorders
10/18/2005US6955810 Method for the treatment of inflammatory disorders
10/18/2005CA2340138C 2-oxo-imidazolidine-4-carboxylic acid hydroxamide compounds that inhibit matrix metalloproteinases
10/18/2005CA2339273C Branched alkyl pyrrolidine-3-carboxylic acids
10/18/2005CA2295063C Indole compounds as anti-inflammatory/analgesic agents
10/18/2005CA2294171C N-hydroxyformamide derivatives as inhibitors of matrix metalloproteinases
10/18/2005CA2148928C Pharmacologically active pyridine derivatives and processes for the preparation thereof
10/13/2005WO2005095443A1 Drug delivery system using peptide modification
10/13/2005WO2005095381A1 Dipeptidyl peptidase inhibitors
10/13/2005WO2005095375A1 Extract of sophora flavescens flavonoids and uses thereof
10/13/2005WO2005095327A1 Aniline derivatives
10/13/2005WO2005094889A1 Remedy or preventive for arthritis
10/13/2005WO2005094885A1 Preventive and/or therapeutic agent for disease accompanied by chronic muscle/skeleton pain
10/13/2005WO2005094858A1 Antidiabetic composition
10/13/2005WO2005094856A1 Preparation and therapeutic uses of plants and plant extracts in the hylocereus genus
10/13/2005WO2005094855A1 Pharmaceutical composition containing salix spec. (willow) extract for the treatment of depressions, sleeping disorders, and states of anxiety and/or restlessness
10/13/2005WO2005094815A1 Dual inhibition of cyclooxygenase-2 and carbonic anhydrase
10/13/2005WO2005094809A1 A composition containing a complex comprising a metal ion and a carboxylate ligand having anti-inflammatory activity
10/13/2005WO2005094789A1 S/o type pharmaceutical preparation and process for producing the same
10/13/2005WO2005076695A3 Methods of modulating neurotrophin-mediated activity
10/13/2005WO2005025552A3 Protein binding compounds
10/13/2005WO2004064717A3 Cop 1 for treatment of inflammatory bowel diseases
10/13/2005WO2003068954A8 Microorganism for genetic therapeutic treatment of proliferative diseases
10/13/2005US20050228170 B7-like molecules and uses thereof
10/13/2005US20050228051 Immunoregulatory compounds and derivatives and methods of treating diseases therewith
10/13/2005US20050228036 3-(arylamino)methylene-1,3-dihydro-2H-indol-2-ones as kinase inhibitors
10/13/2005US20050228025 Substituted oxindole derivatives as tyrosine kinase inhibitors
10/13/2005US20050228018 Chemical compounds
10/13/2005US20050228011 use of carboxy-functional benzofurans or benzothiophenes to treat tumor growth, metastasis, osteoporosis, restenosis, inflammation, macular degeneration, diabetic retinopathy, rheumatoid arthritis, and sickle cell anemia; greater bioavailability or fewer side-effects
10/13/2005US20050228005 Protein kinase inhibitors and uses thereof
10/13/2005US20050227997 Selective inhibition of aggrecanase in osteoarthritis treatment
10/13/2005US20050227994 Decomposition inhibitor for extracellular matrix of cartilage
10/13/2005US20050227991 Containing a piperazine ring, e.g., N'-(4-{4-[5-(1,2-dithiolan-3-yl)pentanoyl]-1-piperazinyl)phenyl)-2-thiophenecarboximidamide and intermediates for preparing them; useful for inhibiting NO synthase and regenerating antioxidants
10/13/2005US20050227988 compounds capable of inhibiting, modulating and/or regulating signal transduction of both receptor-type and non-receptor type tyrosine kinases; gliomas, meningomas, cancers, Hodgkin's disease, retinal vascularization; core structure that comprises a benzazocine moiety
10/13/2005US20050227986 Vanilloid receptor ligands and their use in treatments
10/13/2005US20050227983 Triazine compounds and their analogs, compositions, and methods
10/13/2005US20050227973 Human adam-10 inhibitors
10/13/2005US20050227972 treating disorders of the cardiovascular system; adenosine receptor agonists/antagonists
10/13/2005US20050227967 Treatment of T-helper cell type 2-mediated immune diseases by retinoid antagonists
10/13/2005US20050227963 Antiinflammatory agents
10/13/2005US20050227957 Therapy for oxidation stresses; complex of drug and enzyme mimetics; lipophilic cation moiety covalently bonded to glutathione peroxidase mimetic moiety is selected from the group consisting of: benzisoselenazolones, diaryl diselenides and diaryl selenides
10/13/2005US20050227951 Verification of translation
10/13/2005US20050227948 Hif hydroxylase inhibitors
10/13/2005US20050227916 Administering carrier molecule such as albumin conjugated to mannose-6-phosphate; particularly targeting Hepatic Stellate Cells (HSC); glomeruloscherosis, interstitial fibrosis, lung fibrosis, atherosclerosis, Crohn's disease, colitis ulcerosa, glomerulonephritis and sepsis; diagnosis
10/13/2005US20050227280 Proteases
10/13/2005US20050227277 Apoptosis proteins
10/13/2005US20050226877 administration of a function blocking antibody which is capable of binding an epitope of VLA-1; arthritis
10/13/2005US20050226872 Use of cd25 binding molecules in the treatmnet of inflammatory diseases of the gastrointestinal tract
10/13/2005US20050226870 Administering anti-inflammatory amount of a purified antibody specific against C5, wherein antibody inhibits the cleavage of C5 into C5a and C5b
10/13/2005US20050226813 Labelled somatostatin analogs backbone cyclized through metal complexation
1 ... 636 637 638 639 640 641 642 643 644 645 646 647 648 649 650 651 652 653 654 655 656 ... 1272